If you are experiencing problems downloading PDF or HTML fulltext, our helpdesk recommend clearing your browser cache and trying again. If you need help in clearing your cache, please click here . Still need help? Email email@example.com
A 77‐year‐old man with a 5‐year history of mycosis fungoides (MF) who had received several lines of therapy, including intravenous courses of Methotrexate (MTX) for the past 2 years, went on to develop several ulcerated cutaneous nodules on the left leg. Biopsy
revealed diffuse sheets of EBV‐positive large B cells (CD20+ CD30 ± IgM Lambda), with an angiocentric distribution and a monoclonal IGH gene rearrangement. Although the pathological features were diagnostic for an EBV‐positive diffuse large B‐cell
lymphoma (DLBCL), several possibilities could be considered for assignment to a specific entity: EBV‐positive DLBCL of the elderly, methotrexate‐induced lymphoproliferative disorder (LPD), lymphomatoid granulomatosis, or the more recently described EBV‐positive mucocutaneous
ulcer. The development of EBV+ lymphoproliferations has been reported in two other patients with MF under MTX, and occurred as skin lesions of the leg in one of these and in the current case, which may question the relatedness to primary cutaneous DLCBL, leg‐type.